期刊文献+

阻塞性睡眠呼吸暂停综合征患者多平面手术前后的血压昼夜节律与血清新蝶呤变化 被引量:2

Circadian blood pressure variability and plasma neopterin level before and after surgery for obstructive sleep apnea syndrome
原文传递
导出
摘要 目的 探讨阻塞性睡眠呼吸暂停综合征(OSAS)患者手术治疗前后的血压昼夜节律与血清新蝶呤的变化。方法 连续入院的拟行手术的OSAS患者382例,行睡眠监测后分为3组,轻度OSAS组206例,中度OSAS组108例,重度OSAS组68例。入院1周内检测血清新蝶呤浓度,并同时行24h动态血压监测,术后3个月复查上述指标。结果 手术前血清新蝶呤浓度轻度OSAS组为15.08nmol/L,中度OSAS组为27.68nmol/L,重度OSAS组为37.32nmo/L,术后三组血清新蝶呤浓度分别为9.92nmol/L、15.07nmol/L和8.54nmol/L,三组比较差异有统计学意义(P〈0.05)。手术前三组昼夜血压曲线呈非杓型分别占50.2%、72.7%和86.5%,术后分别为34.8%、48.2%和49.4%,三组比较差异有统计学意义(P〈0.05)。相关分析表明,血压夜间下降百分率与血清新蝶呤浓度呈负相关。结论 血清新蝶呤浓度及血压非杓型比例与OSAS严重程度相关。血压夜间下降百分率与血清新蝶呤浓度呈负相关。手术治疗后血清新蝶呤浓度及非杓型比例均下降。血清新蝶呤浓度可能在OSAS患者血压变异性的发病机制中起一定作用。手术治疗可改善OSAS的血压变异性并减轻炎症反应。 Objective To investigate the change of circadian blood pressure variability (BPV) and plasma neopterin before and after surgey (uvulopalatopharyngoplasty) for patients with obstrcuctive sleep apnea syndrome ( OSAS). Methods A total of 382 OSAS patients underwent uvulopalatopharyngoplasty were divided into three groups based on polysomnography (PSG) results : mild OSAS ( n = 206 ), moderate OSAS ( n = 108 ) and severe OSAS ( n = 68 ) . Plasma neopterin, 24-hour ambulatory blood pressure monitoring (ABPM), PSG were measured before and 3 months after surgery. Results Plasma neopterin increased in proportion to severity of OSAS before surgery ( 15. 08 nmol/L,27. 68 nmol/L and 37. 32 nmol/L in patients with mild to severe OSAS) which were significantly reduced post surgery (9.92 ng/ml, 15. 07 ng/ml and 18.54 ng/ml, all P 〈0. 05 vs. pre-surgery). The incidence of non-dipper curve in three OSAS groups were 50.2% ,72.7% and 86.5%, respectively before surgery and the values decreased to 34. 8%, 48.2% and 49. 2% after surgery (all P 〈0. 05 vs. pre-surgery). Relevance analysis indicates that D-value of nocturnal and diurnal blood pressure was negatively correlated with plasma neopterin. Conclusion Our findings indicated that plasma neopterin and the incidence of non-dipper could reliably reflect OSAS severity and could thus be used to evaluate the surgery efficacy. Plasma neopterin might be an important player in the pathophysiology of OSAS via modulating blood pressure variability.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第2期132-136,共5页 Chinese Journal of Cardiology
关键词 睡眠呼吸暂停综合征 新蝶呤 血压 Sleep apnea syndrome Neopterin Blood pressure
  • 相关文献

参考文献16

  • 1Somers VK,White DP,Amin R,et al.Sleep apnea and cardiovascular disease:an American Heart Association/American College of Cardiology foundation scientific statement from the American Heart Association council for high blood pressure research professional education committee,council on clinical cardiology,stroke council,and council on cardiovascular nursiong in collaboration with the national heart,lung,and blood institute national center on sleep disorders reaearch.J Am Coll Cardiol,2008,52:686-717. 被引量:1
  • 2Blanco F,Cil P,Arco CD,et al.Association of clinic and ambulatory blood pressure with vascular damage in the elderly:the EPICARDIAN study.Blood Press Monit,2006,11:329-335. 被引量:1
  • 3Stolarz-Skrzypek K,Thijs L,Richart T,et al.Blood pressure variability in relation to outcome in the international database of ambulatory blood pressure in relation to cardiovascular outcome.Hypertens Res,2010,33:757-766. 被引量:1
  • 4Gorelick PB.Reducing blood pressure variability to prevent stroke?Lancet Neurol,2010,9:448-449. 被引量:1
  • 5Hansen TW,Thijs L,Li Y,et al.Prognostic value of reading-toreading blood pressure variability over 24 hours in 8938 subjects from 11 populations.Hypertension,2010,55:1049-1057. 被引量:1
  • 6Avanzas P,Arroyo-Espliguero R,Cosín-Sales J,et al.Markers of inflammation and multiple complex steneses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.Heart,2004,90:847. 被引量:1
  • 7Friedman M,lbrahim H,Jeseph NJ.Staging of obstructive sleep apnea/hypopnea syndrome:a guide to appropriate treatment.Laryngoscope,2004,114:454-459. 被引量:1
  • 8Qiu YG,Zhu JH,Tao QM,et al.Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled,nondipping hypertensives.Cardiovasc Drugs Ther,2005,19:189-195. 被引量:1
  • 9Izzedine H,Launay-Vacher V,Deray G.Abnormal blood pressure circadian rhythm:a target organ damage.Int J Cardiol,2006,107:343 -349. 被引量:1
  • 10Madin K,Iqbal P.Twenty-four hour ambulatory blood preesure monito ring:a new tool for determining cardiovascular prognosis.Postgrad Med J,2006,82:548-551. 被引量:1

二级参考文献12

  • 1[1]Peppard P E,Young T,Palta M,et al.Prospective study of theassociation between sleep-disordered breathing and hypertension.N Engl J Med,2000,324(19):1378-1384. 被引量:1
  • 2[2]Kimoff RJ,Brooks D,Horner RL,et al.Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea.Am J Rspir Crit Care Med,1997,156(3Pt 1):886-894. 被引量:1
  • 3[3]Stradling JR,Partlett J,DaviesR J,et al.Effect of short term graded withdrawal of nasal continous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnea.Blood press,1996,5(4):234-240. 被引量:1
  • 4[4]Koskenvuo M,Partinen M,Kaprio J.Snoring and disease.Ann Clin Res,1985,17(5):247-251. 被引量:1
  • 5[5]Savoia C,Schiffrin EL.Inflammation in hypertension.Curr Opin Nephrol Hypertens,2006,15(2):152-158. 被引量:1
  • 6[6]Entzian P,Linnemann K,Schlaak M,Zabel P.Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines.Am J Respir Crit Care Med,1996,153(3):1080-1086. 被引量:1
  • 7[7]Yokoe T,Minoguchi.M K,Matsuo H.Elevated levels of C-reactive protein and interlteukin-6 in patients with obstictive sleep apnea syndrome are decreased nasal continuous positie airway pressure.Circulation,2003,107(8):1129-1134. 被引量:1
  • 8[8]Vgontzas AN,Papanicolaou DA,Bixler EO,et al.Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity.J Clin Endocrinol Metab,1997(82):1313-1316. 被引量:1
  • 9[9]Vgontzas AN,Papanicolaou DA,Bixler EO,et al.Circadian interleukin-6 secretion and quantity and depth of sleep.J Clin Endocrinol Metab,1999(84):2603-2607. 被引量:1
  • 10[10]Lagrand WK,Visser CA,Hermens WT,et al.C-reactive protein as a cardiovascular risk factor:more than an epiphenomenon.Circulation,1999(100):96-102. 被引量:1

共引文献9

同被引文献44

  • 1马磊,热孜叶,周海荣,江华,迟新栋,刘远新.手术治疗伴难治性高血压的阻塞性睡眠呼吸暂停低通气综合征患者的疗效[J].中国老年学杂志,2014,34(3):672-674. 被引量:8
  • 2陈怀京,吴延庆,王小平,丁静,曾祥毅,陈琦.持续气道正压通气治疗对阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血压的影响[J].中华高血压杂志,2010,18(7):681-683. 被引量:11
  • 3Calhoun DA, Jones D, Textor S, et al. Resistant hypertension : diag- nosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committeeof the council for high blood pressure research [ J ]. Hypertension,2008,51(6):1403-1419. 被引量:1
  • 4Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension( ESH ) and of the European Society of Cardiology ( ESC ) [ J ]. J Hypertens ,2007,25 (6) : 1105-1187. 被引量:1
  • 5Jamerson K, Weber MA, Bakris GL, et al. Accomplish trial investi- gators. Berazepril plus amlodipine or hydrochlorot hiazide for hypertension in high-risk patients [ J ]. N Engl J Med, 2008,359 (23) :2417-2428. 被引量:1
  • 6Reico-Rodriguez JI, Gomez-Mareos MA, Patino Alonso MC, et al. Abdominal obesity vs general obesity for identifying arterial stiff- ness, subclinical atherosclerosis and wave reflection in healthy, dia- betics and hpertensive [ J ]. BMC Cardiovasc Disord, 2012 12 (1):3. 被引量:1
  • 7Black HR, Elliot WJ, Grandits, et al. Results of the controlled onset verapamil investigation of cardiovascular endpoints ( CONVONCE ) trial by geographical region [ J ]. ] Hypertens, 2005,23 ( 5 ) : 1099-1106. 被引量:1
  • 8Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitiv- ity of blood pressure in non-diabetic people in China: a dietary intervention study [ J ]. Lancet,2009,373 (9666) :829-835. 被引量:1
  • 9Chan CC, Reid CM, Aw TJ, et al. Do Cox-2 inhibitors raise blood pressure more than monselective NASIDs and placebo? An upda- ted meta-analysis [ J]. J Hypertens,2009,27 (12) :2332-2341. 被引量:1
  • 10Brown M J, Melnnes GT, Papst CC, et al. Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control ( ACCELERATE ) : a randomized, parallel-group trial [ J ]. Lancet,2011,377 ( 9762 ) : 312-320. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部